Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record now indicates that no participants are being sought, signaling that recruitment for this trial has ended. The record has been updated to Revision: v3.6.0, replacing the previous Revision: v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-12T16:46:26.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.5.5 as the latest entry, and the previous Revision: v3.5.4 is no longer listed.
    Difference
    0.1%
    Check dated 2026-06-05T17:12:53.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The history shows a new revision v3.5.4 added and the previous revision v3.5.3 removed, indicating the study record has been refreshed to the latest version.
    Difference
    0.1%
    Check dated 2026-05-15T05:53:27.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    A site release/version label on the page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a platform change rather than an update to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:18.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page history.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:52.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Added updated Study Status and Contacts/Locations sections (version 59, published 2026-03-25) and a deletion on 2026-02-17.
    Difference
    0.3%
    Check dated 2026-03-26T11:31:42.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.